1. Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom;
2. Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands;
3. Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany;
4. Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany;
5. Hopp Children’s Cancer Center, Heidelberg, Germany;
6. Division of Pediatric Neurooncology, DKFZ, DKTK, Heidelberg, Germany;
7. Hematology and Transfusion Medicine, Department of Laboratory Medicine, Biomedical Centre, Lund University, Lund, Sweden;
8. Hematology Clinic, Skåne University Hospital, Lund, Sweden;
9. National Centre of Tumor Diseases, Heidelberg, Germany;
10. NYU Langone Health Care, New York, NY;
11. Division of Cancer Epidemiology, DKFZ, DKTK, Heidelberg, Germany;
12. Biomedical Center, Faculty of Medicine in Pilsen, Charles University in Prague, Pilsen, Czech Republic;
13. Broad Institute, Cambridge, MA; and
14. Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom